etoposide has been researched along with Granulomatosis, Lipid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agostinelli, C; Broccoli, A; Faccioli, L; Pastore Trossello, M; Spinardi, L; Stefoni, V; Zinzani, PL | 1 |
Cappelli, C; Foco, M; Mizzoni, F; Noto, C; Toscano, D; Trasimeni, G; Valentini, D | 1 |
1 review(s) available for etoposide and Granulomatosis, Lipid
Article | Year |
---|---|
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Administration Schedule; Erdheim-Chester Disease; Etoposide; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mitoxantrone; Prednisone; Treatment Outcome; Vincristine | 2012 |
1 other study(ies) available for etoposide and Granulomatosis, Lipid
Article | Year |
---|---|
[Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Child; Diagnosis, Differential; Drug Therapy, Combination; Erdheim-Chester Disease; Etoposide; Female; Follow-Up Studies; Hormones; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Phenotype; Prednisone; Radiography; Somatostatin; Time Factors; Treatment Outcome; Vinblastine | 2004 |